LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

Fort Sheridan Advisors LLC's Holding History (CIK: 0001606666)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 55,177 Value ($000) $92 Avg Close $1.73 Range $1.53 - $2.09
Q3 2025
Shares 55,177 Value ($000) $93 Avg Close $1.18 Range $0.85 - $1.80
Q2 2025
Shares 55,177 Value ($000) $50 Avg Close $0.59 Range $0.37 - $1.15
Q1 2025
Shares 55,177 Value ($000) $25 Avg Close $0.59 Range $0.45 - $0.75
Q4 2024
Shares 55,177 Value ($000) $28 Avg Close $0.73 Range $0.48 - $0.97
Q3 2024
Shares 32,177 Value ($000) $29 Avg Close $0.93 Range $0.77 - $1.15
Q2 2024
Shares 32,177 Value ($000) $32 Avg Close $1.10 Range $0.84 - $1.56
Q1 2024
Shares 32,177 Value ($000) $48 Avg Close $1.13 Range $0.84 - $1.61
Q4 2023
Shares 40,931 Value ($000) $45 Avg Close $1.10 Range $0.90 - $1.37
Q3 2023
Shares 83,931 Value ($000) $99 Avg Close $1.36 Range $1.15 - $1.54
Q2 2023
Shares 83,931 Value ($000) $118 Avg Close $1.38 Range $1.24 - $1.57
Q1 2023
Shares 73,931 Value ($000) $111 Avg Close $1.40 Range $1.16 - $1.58
Q4 2022
Shares 83,931 Value ($000) $98 Avg Close $1.26 Range $1.02 - $1.51
Q3 2022
Shares 83,931 Value ($000) $95 Avg Close $1.47 Range $1.11 - $1.79
Q2 2022
Shares 78,931 Value ($000) $125 Avg Close $1.32 Range $1.10 - $1.64
Q1 2022
Shares 75,931 Value ($000) $117 Avg Close $1.55 Range $1.18 - $2.58
Q4 2021
Shares 52,931 Value ($000) $130 Avg Close $2.34 Range $1.80 - $2.71
Q3 2021
Shares 47,931 Value ($000) $121 Avg Close $2.57 Range $2.26 - $2.90
Q2 2021
Shares 47,931 Value ($000) $137 Avg Close $2.59 Range $2.14 - $3.00
Q1 2021
Shares 44,931 Value ($000) $106 Avg Close $2.40 Range $1.55 - $3.13